EVCARCO (OTC.BB:EVCA) is pleased to present to the shareholders of EVCARCO the latest update from its Italian manufacturer TAZZARI.

Over 6 months have passed since ZERO was launched. While a discerning public admires its technological features, ecological concept, its design and the performance of this all-electric vehicle built using cutting-edge techniques, the TAZZARI team is busy planning and defining the vehicle's coming innovations.

Planned for spring next year there will be a number of innovations that are currently at an advanced stage of development.

These include a driver control panel with touch-screen technology. Part of the dashboard, the new control panel will give the driver easy, finger-tip control over a range of vehicle functions. Its design is essential and ultra-modern and this instrument represents a major innovation in the automotive sector, bringing it closer to that of latest-generation communication devices such as the iPod.

Externally, there will be a number of new optional features such as LED lights and front fog lamps. As far as drivability is concerned, adjustable suspensions are being developed to suit all road types, from urban freeways to off-road surfaces. Further developments for ZERO remain top-secret for the time being, but will be disclosed at the end of the year and will be available in 2011.

EVCARCO Inc. is the Future Driven automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO has developed a dealer network allowing growth into most US States by 2012.

*************************************************

Valassis (NYSE:VCI), one of the nation's leading media and marketing services companies, has been named to this year's InformationWeek 500 list, an annual listing of the nation's most innovative users of business technology. Valassis' submission focused on the innovation of patent-pending Integrated Media Optimization (IMO) engine, the first and only product of its kind in this industry. IMO uses advanced mathematical models to calculate and analyze objectives, budgets, targeting criteria and media scores to produce media recommendations, complete with detailed maps and charts. In its inaugural listing, Valassis ranked in the upper half at 197 out of 500 companies on the list.

Valassis is one of the nation's leading media and marketing services companies, offering unparalleled reach and scale to more than 15,000 advertisers. Its RedPlum media portfolio delivers value on a weekly basis to over 100 million shoppers across a multi-media platform – in-home, in-store and in-motion. Through its digital offerings, including redplum.com, consumers can find compelling national and local deals. Headquartered in Livonia, Michigan with approximately 7,000 associates in 28 states and eight countries, Valassis is widely recognized for its associate and corporate citizenship programs, including its America's Looking for Its Missing Children program. Valassis companies include Valassis Direct Mail, Inc., Valassis Canada, Promotion Watch, Valassis Relationship Marketing Systems, LLC and NCH Marketing Services, Inc.

*************************************************

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) reports that Alexza Pharmaceuticals, Inc. has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug Application (NDA) for AZ-004 (Staccato loxapine) submitted as Adusuve Staccato (loxapine) inhalation aerosol, 5 mg and 10 mg. Valeant's subsidiary, Biovail Laboratories International SRL (BLS), entered into a collaboration and license agreement with Alexza Pharmaceuticals, Inc. in February 2010 for the U.S. and Canadian rights to commercialize AZ-004. AZ-004 is being developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.

*************************************************

Valence Technology, Inc. (NASDAQ: VLNC), a leading U.S. based global manufacturer of advanced energy storage solutions, expects revenue of approximately $12 million for its fiscal 2011 second quarter ended September 30, 2010. This would surpass the high end of the $8 million to $10 million revenue guidance range issued by the Company on August 4, 2010.

Valence Technology is a global leader in the development and manufacture of safe, long-life lithium iron magnesium phosphate advanced energy storage solutions and integrated command and control logic. Headquartered in Austin, Texas, Valence enables and powers some of the world's most innovative and environmentally friendly applications, ranging from commercial electric vehicles to industrial and marine equipment. Valence Technology today offers a proven technology and manufacturing infrastructure that delivers ISO-certified products and processes that are protected by an extensive global patent portfolio. In addition to the corporate headquarters in Texas, Valence Technology has its Research & Development Center in Nevada, its Europe/Asia Pacific Sales office in Northern Ireland and global fulfillment centers in North America and Europe.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received fifteen thousand dollars in cash and thirty-five thousand EVCARCO, Inc. (EVCA.OB) restricted shares for 30 days (which has expired) of advertising services.